The early results of the induction therapy comparison (alemtuzumab versus
basiliximab) were presented at the World Transplant Congress in San
Francisco on 28 July 2014. The slides that were presented can be downloaded
here.
The results were also published in The Lancet and the paper can be
accessed
here.
A press release that accompanied the presentation and publication can be
downloaded
here.
The first results of the maintenance therapy comparison (sirolimus versus tacrolimus) were presented
at the European Society of Transplantation meeting in Barcelona on 25th September 2017.
The slides that were presented can be downloaded
here
We are very grateful to the participants who took part in the trial.